How Moderna’s people strategy helped bring the COVID vaccine to market

Two years ago, few people outside of biopharmaceutical circles had likely heard of the company Moderna. Now, it’s a household name—thanks to its COVID-19 vaccine, which received emergency use authorization by the U.S. Food & Drug Administration at the end of 2020. As of last week, more than 156 million Moderna COVID vaccines have been administered in the U.S. READ MORE